ChinaDaily Briefs

Daily Brief China: L’Occitane, Li Auto , China Resources Beverage, Shulan Health Management, Health And Happiness (H&H) and more

In today’s briefing:

  • L’Occitane (973 HK): Who Owns What, And When
  • Li Auto (LI US): 1Q24, A List of Bad News
  • Pre-IPO China Resources Beverage – Here Are the Concerns and the Risks Behind
  • Shulan Health Management Pre-IPO – Still Ramping up but Only a Small Player
  • Morning Views Asia:


L’Occitane (973 HK): Who Owns What, And When

By David Blennerhassett

  • A fortnight ago, I sought access to L’Occitane (973 HK)‘s lesser-known shareholder register, a byproduct of investigative disclosure reports under Chapter 571, s329 of the Securities and Futures Ordinance.
  • This is the same register I discussed in Giordano (709 HK): A Closer Look At The Shareholder Register Ahead Of The SGM; and one also used by proxy solicitors. 
  • The register confirms what has been long rumoured about a certain shareholder activist. It is also informative for what isn’t present. 

Li Auto (LI US): 1Q24, A List of Bad News

By Ming Lu

  • Operating profit turned negative in 1Q24 compared to 1Q23 due to the price war and the failure of new model.
  • The company disappeared from the industry top-10 list of sales volume and revenue growth slowed down to zero in April.
  • All cross-sectional comparisons suggest a Sell rating for the stock.

Pre-IPO China Resources Beverage – Here Are the Concerns and the Risks Behind

By Xinyao (Criss) Wang

  • Over 92% of CR Beverage’s revenue is from packaged drinking water products, but YoY growth this business is already below industry CAGR, raising concerns about whether future growth will stall.
  • The revenue scale/profitability of CR Beverage are far inferior to Nongfu Spring. In terms of cost control, operational efficiency and the strength of supply chain, CR Beverage is lagging behind.
  • For low-priced packaging water, the nationwide expansion is not a simple task, which will lead to significant cash outflow. Valuation of CR Beverage should be lower than that of peers. 

Shulan Health Management Pre-IPO – Still Ramping up but Only a Small Player

By Ethan Aw

  • Shulan Health Management (1807987D CH)  is looking to raise around US$150m in its Hong Kong IPO. 
  • Shulan Health Management (SHM) is a technology-driven healthcare group in China that integrates healthcare services and medical research and education.
  • In this note, we talk about the firm’s historical performance.

Morning Views Asia:

By Leonard Law, CFA

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.


    💡 Before it’s here, it’s on Smartkarma

    Sign Up for Free

    The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

    • ✓ Unlimited Research Summaries
    • ✓ Personalised Alerts
    • ✓ Custom Watchlists
    • ✓ Company Data and News
    • ✓ Events & Webinars